Cardiac Stem Cell Alliances Include Large Firms; MacroPore “Grows” It Alone

MacroPore Biosurgery insists it will pursue solo development of stem cell therapy for myocardial infarction, even though competitors are increasingly aligning with large cardiovascular device firms